By Abigail Townsend
Date: Wednesday 07 May 2025
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
Patent Woes Threaten Drug Firms | 07-Mar-2011 | New York Times |
Stocks push higher on deals and strong earnings | 09-Feb-2011 | USA Today |
Dow soars to close above 12,000 | 02-Feb-2011 | Wall Street Journal |
Pfizer To Close UK Plant And Axe 2,400 Jobs | 01-Feb-2011 | Sky News |
Despite good earnings reports, stocks tumble | 21-Oct-2009 | Wall Street Journal |
Currency | US Dollars |
Share Price | $ 22.79 |
Change Today | $ -0.09 |
% Change | -0.39 % |
52 Week High | $31.39 |
52 Week Low | $21.59 |
Volume | 48,369,889 |
Shares Issued | 5,667m |
Market Cap | $129,151m |
Beta | 0.35 |
RiskGrade | 102 |
Strong Buy | 3 |
Buy | 4 |
Neutral | 15 |
Sell | 0 |
Strong Sell | 1 |
Total | 23 |
Time | Volume / Share Price |
15:59 | 400 @ $22.78 |
15:59 | 500 @ $22.78 |
15:59 | 200 @ $22.78 |
15:59 | 300 @ $22.78 |
15:59 | 300 @ $22.78 |
You are here: research